|
|
|
|
| LEADER |
01645nam a2200265 4500 |
| 001 |
1/22498 |
| 008 |
020619s19931996lu n000 0 eng |
| 020 |
|
|
|a 9282764273 (v.8)
|
| 020 |
|
|
|a 9282651746 (v.1)
|
| 020 |
|
|
|a 9282692698 (v.7)
|
| 020 |
|
|
|a 928275409X (v. 3 add. 3)
|
| 035 |
|
|
|l 23858
|
| 040 |
|
|
|a GR-PeUP
|
| 082 |
0 |
0 |
|a KET 362.1 RUL
|
| 245 |
0 |
4 |
|a The rules governing medicinal products in the European Union
|
| 260 |
|
|
|a Luxembourg :
|b Office for Official Publications of the European Communities,
|c 1993-1996
|
| 300 |
|
|
|a 3 τ. :
|c 30 εκ.
|
| 505 |
0 |
|
|a V.1 The Rules governing medicinal products for human use in the European Community -- v. 3. Addendum 3. Guidelines medicinal products for human use efficacy -- V. 7. Establishment of maximum residue levels of veterinary medicinal products in foodstuffs of animal origin -- V.8. Establishment of maximum residue levels of veterinary medicinal products in foodstuffs of animal origin : summary reports of the Committee for Veterinary Medicinal Products in support of classification in accordance with Council Regulation (EEC) no. 2377/90
|
| 650 |
|
4 |
|a Drugs
|x Law and legislation
|z European Union countries.
|
| 852 |
|
|
|a INST
|b UNIPILB
|c KET
|e 20041124
|h KET 362.1 RUL
|p 00144449
|q 00144449
|t LOAN
|y 0
|4 1
|
| 852 |
|
|
|a INST
|b UNIPILB
|c KET
|e 20050113
|h KET 362.1 RUL
|p 00144487
|q 00144487
|t LOAN
|y 0
|4 1
|
| 852 |
|
|
|a INST
|b UNIPILB
|c KET
|e 20041207
|h KET 362.1 RUL
|p 00144536
|q 00144536
|t LOAN
|y 0
|4 1
|
| 852 |
|
|
|a INST
|b UNIPILB
|c KET
|e 20041124
|h KET 362.1 RUL
|p 00144565
|q 00144565
|t LOAN
|y 0
|4 1
|
| 856 |
4 |
|
|d /webopac/covers/02/23858_9282651746.jpg
|z (v.1)
|
| 856 |
4 |
|
|d /webopac/covers/02/23858_9282692698.jpg
|z (v.7)
|
